BlackRock Discloses Passive Stake in Cardio Diagnostics Holdings
Ticker: CDIOW · Form: SC 13G · Filed: Feb 2, 2024 · CIK: 1870144
| Field | Detail |
|---|---|
| Company | Cardio Diagnostics Holdings, Inc. (CDIOW) |
| Form Type | SC 13G |
| Filed Date | Feb 2, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, SC-13G
TL;DR
**BlackRock just revealed a stake in CDIO, signaling institutional interest.**
AI Summary
BlackRock Inc., a major investment firm, reported on February 2, 2024, that as of December 31, 2023, it holds a significant stake in Cardio Diagnostics Holdings, Inc. (CDIO). This filing indicates BlackRock's passive ownership, meaning they are not seeking to influence company management. For investors, this signals that a large, reputable institution sees value in CDIO, potentially lending credibility and stability to the stock.
Why It Matters
This filing shows a major institutional investor, BlackRock, has a position in Cardio Diagnostics Holdings, which can be seen as a vote of confidence and may attract other investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of passive ownership by a large institution, which generally reduces perceived risk for a stock.
Analyst Insight
A smart investor would note BlackRock's passive stake as a potential positive signal, but would still conduct independent due diligence on Cardio Diagnostics Holdings, Inc.'s fundamentals and future prospects, as this filing doesn't indicate an active investment strategy or a large percentage ownership.
Key Players & Entities
- BlackRock Inc. (company) — filer of the SC 13G, reporting its ownership
- Cardio Diagnostics Holdings, Inc. (company) — the subject company in which BlackRock holds shares
- December 31, 2023 (date) — the date of the event requiring the filing
- February 2, 2024 (date) — the filing date of the SC 13G
Forward-Looking Statements
- Other institutional investors may increase their scrutiny of Cardio Diagnostics Holdings, Inc. due to BlackRock's disclosed stake. (Cardio Diagnostics Holdings, Inc.) — medium confidence, target: Q2 2024
FAQ
Who filed this SC 13G statement?
This SC 13G statement was filed by BlackRock Inc., a major investment management corporation.
Which company is the subject of BlackRock's filing?
The subject company of this filing is Cardio Diagnostics Holdings, Inc., identified by CIK 0001870144.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of Cardio Diagnostics Holdings, Inc. is 14159C103.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), indicating a passive institutional investor.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on February 2, 2024 regarding Cardio Diagnostics Holdings, Inc. (CDIOW).